Published in PLoS One on October 12, 2011
Platelets increase the proliferation of ovarian cancer cells. Blood (2012) 1.97
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest (2016) 1.45
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer (2014) 1.30
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood (2014) 1.02
Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J Extracell Vesicles (2015) 1.02
Enhancing the accuracy of platelet to lymphocyte ratio after adjustment for large platelet count: a pilot study in breast cancer patients. Int J Surg Oncol (2012) 1.00
Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncol Rep (2013) 0.96
Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. Oncol Lett (2012) 0.94
Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization. Cancer Microenviron (2014) 0.90
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer (2015) 0.87
Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett (2015) 0.84
Rapamycin promoted thrombosis and platelet adhesion to endothelial cells by inducing membrane remodeling. BMC Cell Biol (2014) 0.82
Platelet effects on ovarian cancer. Semin Oncol (2014) 0.82
Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis (2014) 0.82
Role of ADP receptors on platelets in the growth of ovarian cancer. Blood (2017) 0.81
Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer. Oncotarget (2016) 0.81
Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer. Crit Rev Oncol Hematol (2012) 0.80
Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood. Cell Mol Bioeng (2015) 0.80
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer. Cancer Genomics Proteomics (2016) 0.80
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients. BMC Cancer (2016) 0.79
Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion. BMC Cancer (2015) 0.79
Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer. Oncol Lett (2015) 0.78
Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition. J Gynecol Oncol (2013) 0.77
Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma. Oncotarget (2016) 0.77
PTEN plays an important role in thrombin-mediated lung cancer cell functions. Biomed Res Int (2015) 0.76
Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply. Int J Mol Sci (2017) 0.75
Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection. J Clin Transl Hepatol (2017) 0.75
The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol (2016) 0.75
Carcinogenesis of renal cell carcinoma reflected in HLA ligands: A novel approach for synergistic peptide vaccination design. Oncoimmunology (2016) 0.75
SubPatCNV: approximate subspace pattern mining for mapping copy-number variations. BMC Bioinformatics (2015) 0.75
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial. Trials (2017) 0.75
Platelet to lymphocyte ratio and red cell distribution width as prognostic factors for survival and recurrence in patients with oral cancer. Eur Arch Otorhinolaryngol (2017) 0.75
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res (2009) 3.76
Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol (2008) 3.68
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood (2007) 3.38
Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol (2000) 3.30
Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer (2005) 3.20
P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A (1998) 3.02
Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res (1999) 2.96
Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A (1968) 2.95
Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) (1999) 2.85
B7-H1 pathway and its role in the evasion of tumor immunity. J Mol Med (Berl) (2003) 2.48
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood (2004) 2.45
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood (2008) 2.41
A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis (2010) 1.95
Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia (2010) 1.73
Bioinformatic discovery of novel bioactive peptides. Nat Chem Biol (2007) 1.72
Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc Natl Acad Sci U S A (2007) 1.68
Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). Arterioscler Thromb Vasc Biol (2009) 1.64
Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer (2008) 1.55
Cardiolipin deficiency releases cytochrome c from the inner mitochondrial membrane and accelerates stimuli-elicited apoptosis. Cell Death Differ (2006) 1.55
In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol (1998) 1.54
Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models. J Thromb Haemost (2009) 1.51
Moderation of the platelet releasate response by aspirin. Blood (2007) 1.26
Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol (1988) 1.24
Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res (2003) 1.20
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. J Cell Biochem (2008) 1.18
Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'. J Thromb Haemost (2008) 1.18
Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'. J Thromb Haemost (2006) 1.14
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic. Prog Mol Biol Transl Sci (2010) 1.14
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem (2006) 1.13
Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J Thromb Haemost (2008) 1.13
The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stress. Cell Death Dis (2010) 1.07
Protection from tumor necrosis factor-mediated cytolysis by platelets. Am J Pathol (1993) 1.05
The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet (2008) 1.02
The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets. Platelets (2010) 1.01
Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation. Br J Pharmacol (2004) 1.00
Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. J Clin Oncol (2001) 0.99
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies. Biol Chem (2010) 0.96
Malignancies and catastrophic anti-phospholipid syndrome. Clin Rev Allergy Immunol (2009) 0.95
Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clin Exp Metastasis (2009) 0.94
Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum. Mod Pathol (2010) 0.94
Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate. J Pharmacol Exp Ther (2006) 0.93
Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost (2008) 0.91
TRAF2 phosphorylation promotes NF-κB-dependent gene expression and inhibits oxidative stress-induced cell death. Mol Biol Cell (2010) 0.91
Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk. Cancer Res (2004) 0.91
The cytoplasmic adaptor protein X11alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement. FASEB J (2009) 0.88
Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells. Cancer Immunol Immunother (2010) 0.88
Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade. Mol Cancer Res (2010) 0.87
Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein. Int J Cancer (1998) 0.86
Increased synthesis of prostacyclin and thromboxane in human ovarian malignancy. Cancer Res (1988) 0.83
Platelet adhesion assays performed under static conditions. Methods Mol Biol (2004) 0.79
[Chemokine and chemokine receptor related to cancer metastasis]. Gan To Kagaku Ryoho (2010) 0.78
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24
Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol (2009) 5.05
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol (2007) 4.40
Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc (2003) 3.13
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet (2004) 2.75
Role of sulphuric acid, ammonia and galactic cosmic rays in atmospheric aerosol nucleation. Nature (2011) 2.65
CTCF-binding elements mediate control of V(D)J recombination. Nature (2011) 2.62
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst (2009) 2.53
Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer (2008) 2.53
Chemical manipulation of hsp70 ATPase activity regulates tau stability. J Neurosci (2009) 2.05
B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A (2010) 2.03
Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment. J Am Geriatr Soc (2007) 1.73
Bioinformatic discovery of novel bioactive peptides. Nat Chem Biol (2007) 1.72
Evaluation of restorative care vs usual care for older adults receiving an acute episode of home care. JAMA (2002) 1.64
TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. J Immunol (2012) 1.63
Improved RNA quality and TaqMan Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials. BMC Biotechnol (2008) 1.55
The isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res (2006) 1.52
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest (2009) 1.51
Implementation and evaluation of a new automated interactive image analysis system. Acta Cytol (2006) 1.48
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer (2012) 1.48
Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One (2008) 1.48
Hereditary hemochromatosis: a common, often unrecognized, genetic disease. Cleve Clin J Med (2002) 1.47
Skeletogenic fate of zebrafish cranial and trunk neural crest. PLoS One (2012) 1.42
Centrifugal extraction of plasma from whole blood on a rotating disk. Lab Chip (2006) 1.41
mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol (2011) 1.40
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ Res (2006) 1.38
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol (2010) 1.37
Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol Cancer (2006) 1.37
Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. Mod Pathol (2008) 1.35
Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc (2014) 1.31
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab Invest (2008) 1.30
The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J Clin Endocrinol Metab (2006) 1.28
Facilitating Akt clearance via manipulation of Hsp70 activity and levels. J Biol Chem (2009) 1.22
p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol (2008) 1.22
Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma. Am J Clin Pathol (2004) 1.19
Molecular understanding of sulphuric acid-amine particle nucleation in the atmosphere. Nature (2013) 1.17
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res (2009) 1.14
Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis (2010) 1.12
Gleason grade progression is uncommon. Cancer Res (2013) 1.09
Elements between the IgH variable (V) and diversity (D) clusters influence antisense transcription and lineage-specific V(D)J recombination. Proc Natl Acad Sci U S A (2010) 1.08
Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein. PLoS One (2012) 1.08
Inkjet-like printing of single-cells. Lab Chip (2011) 1.05
Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review. Drug Resist Updat (2011) 1.04
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev (2013) 1.04
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry. J Clin Pathol (2012) 1.03
Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol Cancer (2007) 1.03
Array-based capture, distribution, counting and multiplexed assaying of beads on a centrifugal microfluidic platform. Lab Chip (2012) 1.02
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.02
Hailey-Hailey disease: molecular and clinical characterization of novel mutations in the ATP2C1 gene. J Invest Dermatol (2002) 1.01
Prostate cancer: Re-focusing on androgen receptor signaling. Int J Biochem Cell Biol (2007) 0.99
An integrative model for recurrence in ovarian cancer. Mol Cancer (2008) 0.99
Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy. J Infect Dis (2011) 0.98
Impact of a continuous quality improvement initiative on appropriate use of coronary computed tomography angiography. Results from a multicenter, statewide registry, the Advanced Cardiovascular Imaging Consortium. J Am Coll Cardiol (2012) 0.98
The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy. J Thorac Oncol (2012) 0.98
miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma. Int J Gynecol Cancer (2009) 0.97
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. J Natl Cancer Inst (2013) 0.97
Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy. Methods Mol Biol (2009) 0.97
Platelet function and HIV: a case-control study. AIDS (2010) 0.97
Changes in prognostic awareness among seriously ill older persons and their caregivers. J Palliat Med (2006) 0.97
Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival. Cancer Res (2007) 0.96
Centrifugo-pneumatic valving utilizing dissolvable films. Lab Chip (2012) 0.96
Systems-level modeling of cancer-fibroblast interaction. PLoS One (2009) 0.94
Integrated microfluidic array plate (iMAP) for cellular and molecular analysis. Lab Chip (2011) 0.93
Comprehensive integration of homogeneous bioassays via centrifugo-pneumatic cascading. Lab Chip (2013) 0.93
Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland. J Med Microbiol (2011) 0.92
Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer. J Pathol (2012) 0.92
Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines. Arch Pathol Lab Med (2007) 0.92
Atypical chest pain: coronary, aortic, and pulmonary vasculature enhancement at biphasic single-injection 64-section CT angiography. Radiology (2007) 0.92
Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy. J Clin Microbiol (2013) 0.90
Centrifugo-pneumatic valve for metering of highly wetting liquids on centrifugal microfluidic platforms. Lab Chip (2009) 0.90
Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck (2006) 0.89
Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival. Eur J Obstet Gynecol Reprod Biol (2013) 0.89
MIR141 Expression Differentiates Hashimoto Thyroiditis from PTC and Benign Thyrocytes in Irish Archival Thyroid Tissues. Front Endocrinol (Lausanne) (2012) 0.89
Platelet receptor redox regulation. Platelets (2008) 0.88
Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens. J Virol Methods (2008) 0.88